Review



anti p21  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    OriGene anti p21
    Immunohistochemistry with primary <t>anti-p21</t> antibody with positive reaction visible as brown staining. A – weak nuclear reaction in a grade 1 mast cell tumour (MCT); B – moderate nuclear reaction in a grade 2 MCT; C – strong nuclear reaction in a grade 3 MCT
    Anti P21, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/p21+(CDKN1A)+Mouse+Monoclonal+Antibody/pmc10730558-46-21-16
    Average 91 stars, based on 1 article reviews
    anti p21 - by Bioz Stars, 2026-11
    91/100 stars

    Images

    1) Product Images from "Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system"

    Article Title: Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system

    Journal: Journal of Veterinary Research

    doi: 10.2478/jvetres-2023-0066

    Immunohistochemistry with primary anti-p21 antibody with positive reaction visible as brown staining. A – weak nuclear reaction in a grade 1 mast cell tumour (MCT); B – moderate nuclear reaction in a grade 2 MCT; C – strong nuclear reaction in a grade 3 MCT
    Figure Legend Snippet: Immunohistochemistry with primary anti-p21 antibody with positive reaction visible as brown staining. A – weak nuclear reaction in a grade 1 mast cell tumour (MCT); B – moderate nuclear reaction in a grade 2 MCT; C – strong nuclear reaction in a grade 3 MCT

    Techniques Used: Immunohistochemistry, Staining

    Frequency of immunoreactivity for p21 protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **_ P-value < 0.01; *** P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction
    Figure Legend Snippet: Frequency of immunoreactivity for p21 protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **_ P-value < 0.01; *** P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction

    Techniques Used:

    Related Articles

    Immunohistochemistry:

    Article Title: Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system
    Article Snippet: Next, the tissues were permeabilised in 3% bovine serum albumin–phosphate-buffered saline (PBS) solution for 30 min at room temperature, then incubated with primary antibodies for 1 h at room temperature in a humidified chamber.Next, the tissues were permeabilised in 3% bovine serum albumin–phosphate-buffered saline (PBS) solution for 30 min at room temperature, then incubated with primary antibodies for 1 h at room temperature in a humidified chamber.. The primary antibodies used in this study, all canine-specific, were as follows: anti-CB2R (Cat. No. TA317640; OriGene Technologies, Rockville, MD, USA), anti-p21 (Cat. No. M7202; clone SX118, Agilent Dako, Santa Clara, CA, USA) and anti-MMP-1 (Cat. No. ABIN2777120; antibodies-online, Aachen, Germany), diluted 1 : 200, 1 : 50 and 1 : 500, respectively.. Tris-buffered saline, (Sigma-Aldrich, St. Louis, MO, USA) was used instead of the primary antibody to obtain the negative control for the IHC test.Tris-buffered saline, (Sigma-Aldrich, St. Louis, MO, USA) was used instead of the primary antibody to obtain the negative control for the IHC test.

    Staining:

    Article Title: Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system
    Article Snippet: Next, the tissues were permeabilised in 3% bovine serum albumin–phosphate-buffered saline (PBS) solution for 30 min at room temperature, then incubated with primary antibodies for 1 h at room temperature in a humidified chamber.Next, the tissues were permeabilised in 3% bovine serum albumin–phosphate-buffered saline (PBS) solution for 30 min at room temperature, then incubated with primary antibodies for 1 h at room temperature in a humidified chamber.. The primary antibodies used in this study, all canine-specific, were as follows: anti-CB2R (Cat. No. TA317640; OriGene Technologies, Rockville, MD, USA), anti-p21 (Cat. No. M7202; clone SX118, Agilent Dako, Santa Clara, CA, USA) and anti-MMP-1 (Cat. No. ABIN2777120; antibodies-online, Aachen, Germany), diluted 1 : 200, 1 : 50 and 1 : 500, respectively.. Tris-buffered saline, (Sigma-Aldrich, St. Louis, MO, USA) was used instead of the primary antibody to obtain the negative control for the IHC test.Tris-buffered saline, (Sigma-Aldrich, St. Louis, MO, USA) was used instead of the primary antibody to obtain the negative control for the IHC test.



    Similar Products

    96
    Santa Cruz Biotechnology mouse anti p21 f 5
    FOXM1 regulates DNA damage accrual in aging. (a) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in HDFs derived from young or aged donors. Arrowheads point to magnified nuclei in the insets. (b) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDFs from donors grouped by age intervals as indicated. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (c) Representative immunofluorescence images of p53 (green) and <t>p21</t> (magenta) in HDFs. (d) Percentage of HDFs staining positive for p53 or p21. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (e) GSEA analysis comparing older (> 40‐year‐old) versus younger (1‐ to 40‐year‐old) cohorts using the “Hallmark” collection from MSigDB. Significant gene sets are ordered by normalized enrichment score (NES), and the top 25 terms are ranked by p adjust . (f) GSEA analysis of older versus younger cohorts using MSigDB gene sets related to DNA repair. Significantly enriched gene sets are ordered by NES (see also Supplementary Table ). (g) Transcription factor enrichment analysis for downregulated DNA repair genes using ChEA3. Transcription factors are ordered by the number of gene associations. (h) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young HDFs treated with either mock or FOXM1 RNAi. Arrowheads indicate nuclei shown in the insets. (i) Percentage of nuclei positive for γH2AX or 53BP1 foci in mock or FOXM1 RNAi‐treated HDFs. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (j) Representative comet assay images and (k) quantification of the comet olive moment in mock or FOXM1 RNAi‐treated young HDFs ( n ≥ 163 cells, 3 biological replicates). Color scale used for signal intensity. (l) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young or aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 (FOXM1 OE). White lines delimitate nuclear areas. (m) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDF samples as mentioned in (l). Dots represent independent experiments, using two biological replicates per group ( n ≥ 350 cells per experiment). (n) Representative comet assay images and (o), quantification of the comet olive moment in aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 ( n ≥ 142 cells, 4 independent experiments using 2 biological replicates). Color scale used for signal intensity. Scale bars: 20 μm (a, c, h, i) or 50 μm (j, n). Error bars indicate standard deviation. Statistics performed using the two‐tailed Fisher's exact test (b, d, i, m) and the Mann–Whitney test (k, o). Statistical analysis of the RNA‐seq data described in Section .
    Mouse Anti P21 F 5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/p21+Antibody/pmc13774038-228-74-78
    Average 96 stars, based on 1 article reviews
    mouse anti p21 f 5 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology f 5
    FOXM1 regulates DNA damage accrual in aging. (a) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in HDFs derived from young or aged donors. Arrowheads point to magnified nuclei in the insets. (b) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDFs from donors grouped by age intervals as indicated. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (c) Representative immunofluorescence images of p53 (green) and <t>p21</t> (magenta) in HDFs. (d) Percentage of HDFs staining positive for p53 or p21. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (e) GSEA analysis comparing older (> 40‐year‐old) versus younger (1‐ to 40‐year‐old) cohorts using the “Hallmark” collection from MSigDB. Significant gene sets are ordered by normalized enrichment score (NES), and the top 25 terms are ranked by p adjust . (f) GSEA analysis of older versus younger cohorts using MSigDB gene sets related to DNA repair. Significantly enriched gene sets are ordered by NES (see also Supplementary Table ). (g) Transcription factor enrichment analysis for downregulated DNA repair genes using ChEA3. Transcription factors are ordered by the number of gene associations. (h) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young HDFs treated with either mock or FOXM1 RNAi. Arrowheads indicate nuclei shown in the insets. (i) Percentage of nuclei positive for γH2AX or 53BP1 foci in mock or FOXM1 RNAi‐treated HDFs. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (j) Representative comet assay images and (k) quantification of the comet olive moment in mock or FOXM1 RNAi‐treated young HDFs ( n ≥ 163 cells, 3 biological replicates). Color scale used for signal intensity. (l) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young or aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 (FOXM1 OE). White lines delimitate nuclear areas. (m) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDF samples as mentioned in (l). Dots represent independent experiments, using two biological replicates per group ( n ≥ 350 cells per experiment). (n) Representative comet assay images and (o), quantification of the comet olive moment in aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 ( n ≥ 142 cells, 4 independent experiments using 2 biological replicates). Color scale used for signal intensity. Scale bars: 20 μm (a, c, h, i) or 50 μm (j, n). Error bars indicate standard deviation. Statistics performed using the two‐tailed Fisher's exact test (b, d, i, m) and the Mann–Whitney test (k, o). Statistical analysis of the RNA‐seq data described in Section .
    F 5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/p21/pmc13774038-235-40-42
    Average 96 stars, based on 1 article reviews
    f 5 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology p21
    Immunohistochemical analysis of p16 and <t>p21</t> in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
    P21, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/p21/pmc13755069-82-21-25
    Average 96 stars, based on 1 article reviews
    p21 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti p21
    Immunohistochemical analysis of p16 and <t>p21</t> in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
    Anti P21, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/P21+Antibody/pm42998704-206-3-7
    Average 96 stars, based on 1 article reviews
    anti p21 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech p21
    Immunohistochemical analysis of p16 and <t>p21</t> in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
    P21, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/P21+Antibody/pm42994721-88-93-96
    Average 96 stars, based on 1 article reviews
    p21 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    ABclonal Biotechnology p21
    Immunohistochemical analysis of p16 and <t>p21</t> in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
    P21, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/%5BKO+Validated%5D+CDKN1A%2Fp21CIP1+Rabbit+mAb/pm42993772-63-28-29
    Average 95 stars, based on 1 article reviews
    p21 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti p21
    Immunohistochemical analysis of p16 and <t>p21</t> in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.
    Anti P21, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p21/p21+Waf1%2FCip1+Rabbit+mAb/pm42988019-116-39-41
    Average 97 stars, based on 1 article reviews
    anti p21 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    FOXM1 regulates DNA damage accrual in aging. (a) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in HDFs derived from young or aged donors. Arrowheads point to magnified nuclei in the insets. (b) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDFs from donors grouped by age intervals as indicated. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (c) Representative immunofluorescence images of p53 (green) and p21 (magenta) in HDFs. (d) Percentage of HDFs staining positive for p53 or p21. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (e) GSEA analysis comparing older (> 40‐year‐old) versus younger (1‐ to 40‐year‐old) cohorts using the “Hallmark” collection from MSigDB. Significant gene sets are ordered by normalized enrichment score (NES), and the top 25 terms are ranked by p adjust . (f) GSEA analysis of older versus younger cohorts using MSigDB gene sets related to DNA repair. Significantly enriched gene sets are ordered by NES (see also Supplementary Table ). (g) Transcription factor enrichment analysis for downregulated DNA repair genes using ChEA3. Transcription factors are ordered by the number of gene associations. (h) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young HDFs treated with either mock or FOXM1 RNAi. Arrowheads indicate nuclei shown in the insets. (i) Percentage of nuclei positive for γH2AX or 53BP1 foci in mock or FOXM1 RNAi‐treated HDFs. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (j) Representative comet assay images and (k) quantification of the comet olive moment in mock or FOXM1 RNAi‐treated young HDFs ( n ≥ 163 cells, 3 biological replicates). Color scale used for signal intensity. (l) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young or aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 (FOXM1 OE). White lines delimitate nuclear areas. (m) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDF samples as mentioned in (l). Dots represent independent experiments, using two biological replicates per group ( n ≥ 350 cells per experiment). (n) Representative comet assay images and (o), quantification of the comet olive moment in aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 ( n ≥ 142 cells, 4 independent experiments using 2 biological replicates). Color scale used for signal intensity. Scale bars: 20 μm (a, c, h, i) or 50 μm (j, n). Error bars indicate standard deviation. Statistics performed using the two‐tailed Fisher's exact test (b, d, i, m) and the Mann–Whitney test (k, o). Statistical analysis of the RNA‐seq data described in Section .

    Journal: Aging Cell

    Article Title: FOXM1 Expression Enhances DNA Repair in Aged Cells to Maintain the Peripheral Heterochromatin Barrier Against Senescence Enhancers

    doi: 10.1111/acel.70844

    Figure Lengend Snippet: FOXM1 regulates DNA damage accrual in aging. (a) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in HDFs derived from young or aged donors. Arrowheads point to magnified nuclei in the insets. (b) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDFs from donors grouped by age intervals as indicated. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (c) Representative immunofluorescence images of p53 (green) and p21 (magenta) in HDFs. (d) Percentage of HDFs staining positive for p53 or p21. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (e) GSEA analysis comparing older (> 40‐year‐old) versus younger (1‐ to 40‐year‐old) cohorts using the “Hallmark” collection from MSigDB. Significant gene sets are ordered by normalized enrichment score (NES), and the top 25 terms are ranked by p adjust . (f) GSEA analysis of older versus younger cohorts using MSigDB gene sets related to DNA repair. Significantly enriched gene sets are ordered by NES (see also Supplementary Table ). (g) Transcription factor enrichment analysis for downregulated DNA repair genes using ChEA3. Transcription factors are ordered by the number of gene associations. (h) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young HDFs treated with either mock or FOXM1 RNAi. Arrowheads indicate nuclei shown in the insets. (i) Percentage of nuclei positive for γH2AX or 53BP1 foci in mock or FOXM1 RNAi‐treated HDFs. Dots represent biological replicates of distinct ages ( n = 400 cells per replicate). (j) Representative comet assay images and (k) quantification of the comet olive moment in mock or FOXM1 RNAi‐treated young HDFs ( n ≥ 163 cells, 3 biological replicates). Color scale used for signal intensity. (l) Representative immunofluorescence images of γH2AX (green) and 53BP1 (magenta) in young or aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 (FOXM1 OE). White lines delimitate nuclear areas. (m) Percentage of nuclei positive for γH2AX or 53BP1 foci in HDF samples as mentioned in (l). Dots represent independent experiments, using two biological replicates per group ( n ≥ 350 cells per experiment). (n) Representative comet assay images and (o), quantification of the comet olive moment in aged HDFs transduced with empty lentiviral vector or overexpressing FOXM1 ( n ≥ 142 cells, 4 independent experiments using 2 biological replicates). Color scale used for signal intensity. Scale bars: 20 μm (a, c, h, i) or 50 μm (j, n). Error bars indicate standard deviation. Statistics performed using the two‐tailed Fisher's exact test (b, d, i, m) and the Mann–Whitney test (k, o). Statistical analysis of the RNA‐seq data described in Section .

    Article Snippet: Membranes were blocked for 1 h with 3% BSA prepared in TBS‐T (50 mM Tris‐HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween‐20), and incubated overnight at 4°C with the indicated primary antibodies diluted in TBS‐T + 1% BSA: mouse anti‐GAPDH (#60004, ProteinTech Group, 1:30,000), mouse anti‐α‐tubulin (T5168, Sigma‐Aldrich, 1:100,000), rabbit anti‐FOXM1 (13147‐1‐AP, Proteintech Group, 1:1500), mouse anti‐G9a (PP‐A8620A‐00, R&D Systems, 1:1000), rabbit anti‐H3K9me2 (#39239, Active Motif, 1:2000), mouse anti‐H3K9me2 (NBP2‐59294, Novus Biologicals, 1:1000), mouse anti‐p21 (F‐5) (sc‐6246, Santa Cruz Biotechnology, 1:200), and mouse anti‐E2F1 (KH95) (sc‐251, Santa Cruz Biotechnology, 1:200).

    Techniques: Immunofluorescence, Derivative Assay, Staining, Analysis, Single Cell Gel Electrophoresis, Transduction, Plasmid Preparation, Standard Deviation, Two Tailed Test, MANN-WHITNEY, RNA Sequencing, DNA Synthesis, Non-Homologous End Joining

    FOXM1‐driven maintenance of H3K9me2 occurs at H3K27ac‐marked enhancers to counteract senescence. (a) Volcano plots showing changes in H3K9me2 signal intensity at H3K27ac‐marked regions overlapping ENCODE enhancers in FOXM1 RNAi or FOXM1 OE. Numbers indicate the number of differentially bound H3K9me2 regions. (b) Volcano plots showing changes in H3K27ac signal at ENCODE enhancers for FOXM1 RNAi and FOXM1 OE, with colored points indicating regions where changes in H3K9me2 signal also occur and gray points indicating regions with no change in H3K9me2 signal. Color gradient indicates the Log2FC of the H3K27ac signal at regions changing H3K9me2 levels. (c) Genomic region set enrichment analysis for regions changing H3K9me2 levels at H3K27ac‐marked enhancers. (d) Bar plots comparing the proportion of H3K27ac‐marked enhancers gaining/losing signal at regions where a change versus no change in H3K9me2 occurred. (e) GREAT enrichment plots for regions that, in FOXM1 RNAi, lose H3K9me2 signal intensity at H3K27ac‐marked enhancer (left) and lose H3K9me2 signal intensity at H3K27ac‐marked enhancer gaining H3K27ac signal (right). Gene sets related to senescence and inflammation were used as before. Dot size indicates −log 10 of adjusted p ‐value. (f) GREAT enrichment dot plots for regions that, in FOXM1 OE, gain H3K9me2 signal intensity at H3K27ac‐marked enhancer (left) and gain H3K9me2 signal intensity at H3K27ac‐marked enhancer losing H3K27ac signal (right). (g) Genomic tracks representing epigenetic features in the CXCL locus in chromosome 4 and its associated super enhancer (yellow highlight). Top bars in blue and red represent regions changing H3K9me2/H3K27ac signal in FOXM1 RNAi and FOXM1 OE respectively. CXCL family genes are highlighted in pink. Heatmap indicates z ‐scored gene expression values (transcripts per million) from RNA‐seq data, from lower (blue) to higher (red). Different overlapping shades represent different individuals. Tracks for ENCODE cCREs and enhancer‐gene interactions from GeneHancer (UCSC Genome Browser) are also displayed. (h) Representative images of Lamin B1 (green) and p16 (magenta) immunostainings in young HDFs treated either with G9ai or vehicle control (DMSO). (i, j) Quantification of Lamin B1 nuclear levels (i) and p16‐positive nuclei (j) in young HDFs treated as mentioned in (h) ( n = 900 cells from 3 biological replicates). (k) Representative images of p53 (green) and p21 (magenta) immunostainings in young HDFs treated either with DMSO or G9ai. (l, m) Quantification of p53‐positive (l) and p21‐positive (m) nuclei in young HDFs treated as mentioned in (k) ( n = 900 cells obtained from 3 biological replicates). (n) Model representing FOXM1‐mediated genoprotection via DNA repair gene expression and the recovery of G9a methyltransferase activity sustaining H3K9me2 guidepost for peripheral heterochromatin. Scale bars: 20 μm (h, k). Statistics were performed using the Mann–Whitney test (i), two‐tailed Fisher's exact test (d, j, l, m). Statistical analyses of sequencing data are described in Section .

    Journal: Aging Cell

    Article Title: FOXM1 Expression Enhances DNA Repair in Aged Cells to Maintain the Peripheral Heterochromatin Barrier Against Senescence Enhancers

    doi: 10.1111/acel.70844

    Figure Lengend Snippet: FOXM1‐driven maintenance of H3K9me2 occurs at H3K27ac‐marked enhancers to counteract senescence. (a) Volcano plots showing changes in H3K9me2 signal intensity at H3K27ac‐marked regions overlapping ENCODE enhancers in FOXM1 RNAi or FOXM1 OE. Numbers indicate the number of differentially bound H3K9me2 regions. (b) Volcano plots showing changes in H3K27ac signal at ENCODE enhancers for FOXM1 RNAi and FOXM1 OE, with colored points indicating regions where changes in H3K9me2 signal also occur and gray points indicating regions with no change in H3K9me2 signal. Color gradient indicates the Log2FC of the H3K27ac signal at regions changing H3K9me2 levels. (c) Genomic region set enrichment analysis for regions changing H3K9me2 levels at H3K27ac‐marked enhancers. (d) Bar plots comparing the proportion of H3K27ac‐marked enhancers gaining/losing signal at regions where a change versus no change in H3K9me2 occurred. (e) GREAT enrichment plots for regions that, in FOXM1 RNAi, lose H3K9me2 signal intensity at H3K27ac‐marked enhancer (left) and lose H3K9me2 signal intensity at H3K27ac‐marked enhancer gaining H3K27ac signal (right). Gene sets related to senescence and inflammation were used as before. Dot size indicates −log 10 of adjusted p ‐value. (f) GREAT enrichment dot plots for regions that, in FOXM1 OE, gain H3K9me2 signal intensity at H3K27ac‐marked enhancer (left) and gain H3K9me2 signal intensity at H3K27ac‐marked enhancer losing H3K27ac signal (right). (g) Genomic tracks representing epigenetic features in the CXCL locus in chromosome 4 and its associated super enhancer (yellow highlight). Top bars in blue and red represent regions changing H3K9me2/H3K27ac signal in FOXM1 RNAi and FOXM1 OE respectively. CXCL family genes are highlighted in pink. Heatmap indicates z ‐scored gene expression values (transcripts per million) from RNA‐seq data, from lower (blue) to higher (red). Different overlapping shades represent different individuals. Tracks for ENCODE cCREs and enhancer‐gene interactions from GeneHancer (UCSC Genome Browser) are also displayed. (h) Representative images of Lamin B1 (green) and p16 (magenta) immunostainings in young HDFs treated either with G9ai or vehicle control (DMSO). (i, j) Quantification of Lamin B1 nuclear levels (i) and p16‐positive nuclei (j) in young HDFs treated as mentioned in (h) ( n = 900 cells from 3 biological replicates). (k) Representative images of p53 (green) and p21 (magenta) immunostainings in young HDFs treated either with DMSO or G9ai. (l, m) Quantification of p53‐positive (l) and p21‐positive (m) nuclei in young HDFs treated as mentioned in (k) ( n = 900 cells obtained from 3 biological replicates). (n) Model representing FOXM1‐mediated genoprotection via DNA repair gene expression and the recovery of G9a methyltransferase activity sustaining H3K9me2 guidepost for peripheral heterochromatin. Scale bars: 20 μm (h, k). Statistics were performed using the Mann–Whitney test (i), two‐tailed Fisher's exact test (d, j, l, m). Statistical analyses of sequencing data are described in Section .

    Article Snippet: Membranes were blocked for 1 h with 3% BSA prepared in TBS‐T (50 mM Tris‐HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween‐20), and incubated overnight at 4°C with the indicated primary antibodies diluted in TBS‐T + 1% BSA: mouse anti‐GAPDH (#60004, ProteinTech Group, 1:30,000), mouse anti‐α‐tubulin (T5168, Sigma‐Aldrich, 1:100,000), rabbit anti‐FOXM1 (13147‐1‐AP, Proteintech Group, 1:1500), mouse anti‐G9a (PP‐A8620A‐00, R&D Systems, 1:1000), rabbit anti‐H3K9me2 (#39239, Active Motif, 1:2000), mouse anti‐H3K9me2 (NBP2‐59294, Novus Biologicals, 1:1000), mouse anti‐p21 (F‐5) (sc‐6246, Santa Cruz Biotechnology, 1:200), and mouse anti‐E2F1 (KH95) (sc‐251, Santa Cruz Biotechnology, 1:200).

    Techniques: Analysis, Gene Expression, RNA Sequencing, Control, Activity Assay, MANN-WHITNEY, Two Tailed Test, Sequencing

    Immunohistochemical analysis of p16 and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.

    Journal: Aging Cell

    Article Title: Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation

    doi: 10.1111/acel.70828

    Figure Lengend Snippet: Immunohistochemical analysis of p16 and p21 in liver tissue. (A, B) Representative immunohistochemistry images of (A) p16 and (B) p21 staining in DBD and DCD liver tissue sections. Scale bars represent 250 μm. (C, D) Quantification of (C) p16‐positive and (D) p21‐positive stained nuclei in DBD and DCD. (E, F) Expression of (E) CDKN2A (p16 INK4a /p19 ARF ) and (F) CDKN1A (p21 CIP1 ) in DBD and DCD, with a higher expression of CDKN2A (p16 INK4a /p19 ARF ) in DCD grafts ( p = 0.229) and an upregulation of CDKN1A (p21 CIP1 ) in DBD grafts ( p < 0.001). DBD; donation after brain death, DCD; donation after circulatory death.

    Article Snippet: Formalin‐fixed paraffin‐embedded tissue sections were cut at 4 μm and stained for p16 (Rabbit anti‐p16 Sc‐1207, Santa Cruz, dilution 1:150) and p21 (Rabbit anti‐p21 Sc‐471, Santa Cruz, dilution 1:400).

    Techniques: Immunohistochemical staining, Analysis, Tissue, Immunohistochemistry, Staining, Expressing

    External cohort analysis of all available transcripts and senescence‐associated gene panels. (A) PCA clustering of DBD and DCD livers using all available gene transcripts in the external dataset. The analysis was repeated after restricting to transcripts overlapping with (B) the SenMayo gene panel, and (C) the curated liver‐specific SASP‐associated gene panel. (D) CDKN1A (p21 CIP1 ) expression was higher in DBD compared to DCD grafts ( p < 0.001). DBD, donation after brain death; DCD, donation after circulatory death; PCA, principal component analysis; SASP, senescence‐associated secretory phenotype.

    Journal: Aging Cell

    Article Title: Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation

    doi: 10.1111/acel.70828

    Figure Lengend Snippet: External cohort analysis of all available transcripts and senescence‐associated gene panels. (A) PCA clustering of DBD and DCD livers using all available gene transcripts in the external dataset. The analysis was repeated after restricting to transcripts overlapping with (B) the SenMayo gene panel, and (C) the curated liver‐specific SASP‐associated gene panel. (D) CDKN1A (p21 CIP1 ) expression was higher in DBD compared to DCD grafts ( p < 0.001). DBD, donation after brain death; DCD, donation after circulatory death; PCA, principal component analysis; SASP, senescence‐associated secretory phenotype.

    Article Snippet: Formalin‐fixed paraffin‐embedded tissue sections were cut at 4 μm and stained for p16 (Rabbit anti‐p16 Sc‐1207, Santa Cruz, dilution 1:150) and p21 (Rabbit anti‐p21 Sc‐471, Santa Cruz, dilution 1:400).

    Techniques: Analysis, Expressing